Drug
Bln 481
Bln 481: highest development phase Phase 1, developed by Beeline Medicines Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Beeline Medicines Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| BLN-481 NCT07903064 | Phase 1 |
Latest
No recent events.
Follow Bln 481 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.